| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.0B | $1.1B | $1.0B | $1.1B | $0.2B | $0.3B | $0.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.0B | $-0.1B | $0.0B | $0.0B | $-0.0B | $-0.1B | $-0.1B |
| EPS (Basic) | $23.07 | $4.28 | $-8.34 | $2.97 | $2.00 | $-0.83 | — | — |
| EPS (Diluted) | $21.46 | $4.13 | $-8.34 | $2.85 | $1.93 | $-0.83 | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.2B | $16.4B | $12.5B | $12.4B | $12.1B | $10.7B | $10.4B | $9.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.3B | $0.4B | $0.3B |
| Total Liabilities | $15.5B | $15.9B | $12.1B | $11.9B | $11.7B | $10.2B | $10.0B | $8.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.6B | $0.4B | — | — | — | — | — | $0.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.7B | $-0.6B | $0.0B | $0.2B | $-0.5B | $0.3B | $0.2B | $0.3B |
| Investing Cash Flow | $1.8B | $0.4B | $-0.1B | $-0.1B | $-1.0B | $-0.5B | $-0.6B | $-0.3B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-1.1B | $0.2B | $0.1B | $-0.0B | $1.4B | $0.1B | $0.5B | $0.2B |